These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1084736)

  • 21. [Why does a tumor grow?].
    Dosne Pasqualini C; Laguens RP; Colmerauer ME; Segal A
    Medicina (B Aires); 1974; 34(6):659-64. PubMed ID: 4617837
    [No Abstract]   [Full Text] [Related]  

  • 22. "Immune" RNA--a new model for the immunotherapy of cancer.
    Pilch YH
    Cancer Chemother Rep 3; 1973 Mar; 4(2):287-92. PubMed ID: 4729332
    [No Abstract]   [Full Text] [Related]  

  • 23. Neoplastic growth: the consequence of evolutionary malignant resistance to chronic damage for survival of cells (review of a new theory of the origin of cancer).
    Monceviciūte-Eringiene E
    Med Hypotheses; 2005; 65(3):595-604. PubMed ID: 15919162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regulatory problems in tumor immunology].
    Pasternak G
    Allerg Immunol (Leipz); 1973; 19(2-4):307-19. PubMed ID: 4281633
    [No Abstract]   [Full Text] [Related]  

  • 25. Cancer: the role of extracellular disease.
    Schwartz L; Balosso J; Baillet F; Brun B; Amman JP; Sasco AJ
    Med Hypotheses; 2002 Apr; 58(4):340-6. PubMed ID: 12027530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunotherapy of cancer.
    Parker CW
    Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
    [No Abstract]   [Full Text] [Related]  

  • 27. [Humoral and cellular immunity in patients with non-lymphoid and solid tumors. Correlation with the tumoral status, response to the treatment and survival].
    Simo-Camps E; Anguera A; Vich J; Sala F; Vidal-Ribas A; Sarrias R; Gri E; Puigdollers J
    Rev Clin Esp; 1976 Jan; 140(1):13-8. PubMed ID: 1251051
    [No Abstract]   [Full Text] [Related]  

  • 28. Dendritic cells and tumor immunity.
    Gunzer M; Jänich S; Varga G; Grabbe S
    Semin Immunol; 2001 Oct; 13(5):291-302. PubMed ID: 11502164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What's new in surgery. Tumors.
    Fisher B
    Surg Gynecol Obstet; 1973 Feb; 136(2):216-9. PubMed ID: 4631364
    [No Abstract]   [Full Text] [Related]  

  • 30. Introduction: diagnosis and immunotherapy of cancer.
    Klein E
    Natl Cancer Inst Monogr; 1972 Dec; 35():331-9. PubMed ID: 4349151
    [No Abstract]   [Full Text] [Related]  

  • 31. Summary of the conference on immunology of carcinogensis.
    Baker CG
    Natl Cancer Inst Monogr; 1972 Dec; 35():445-60. PubMed ID: 4572835
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular imaging of cell-mediated cancer immunotherapy.
    Lucignani G; Ottobrini L; Martelli C; Rescigno M; Clerici M
    Trends Biotechnol; 2006 Sep; 24(9):410-8. PubMed ID: 16870284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evolutionary model of carcinogenesis.
    Gatenby RA; Vincent TL
    Cancer Res; 2003 Oct; 63(19):6212-20. PubMed ID: 14559806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacillus Calmette-Guerin in the treatment of neoplastic disease.
    Laucius JF; Bodurtha AJ; Mastrangelo MJ; Creech RH
    J Reticuloendothel Soc; 1974 Dec; 16(6):347-73. PubMed ID: 4616079
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunosuppression and cancer: clinical aspects].
    Brouet JC
    Bull Cancer; 1983; 70(1):40-6. PubMed ID: 6839033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.
    Sica A; Schioppa T; Mantovani A; Allavena P
    Eur J Cancer; 2006 Apr; 42(6):717-27. PubMed ID: 16520032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modern knowledge of the biology of cancer].
    García-García G; Benítez-Bribiesca L; Salamanca-Gómez F; Kretschmer R
    Gac Med Mex; 1989; 125(3-4):69-88. PubMed ID: 2561280
    [No Abstract]   [Full Text] [Related]  

  • 38. Recursive causality in evolution: a model for epigenetic mechanisms in cancer development.
    Haslberger A; Varga F; Karlic H
    Med Hypotheses; 2006; 67(6):1448-54. PubMed ID: 16844314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible significance of immune recognition of preneoplastic and neoplastic cell surfaces.
    Lappé MA
    Natl Cancer Inst Monogr; 1972 Dec; 35():49-55. PubMed ID: 4659057
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune cells as anti-cancer therapeutic targets and tools.
    Johansson M; Tan T; de Visser KE; Coussens LM
    J Cell Biochem; 2007 Jul; 101(4):918-26. PubMed ID: 17265430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.